Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)
A. P. Jewell
School of Biological Sciences, Kingston University, Surrey, UK
Search for more papers by this authorK. Patterson
School of Biological Sciences, Kingston University, Surrey, UK
Search for more papers by this authorK. Yong
Haematology, Royal Free and Middlesex Hospital Medical School, London, UK and
Search for more papers by this authorA. P. Jewell
School of Biological Sciences, Kingston University, Surrey, UK
Search for more papers by this authorK. Patterson
School of Biological Sciences, Kingston University, Surrey, UK
Search for more papers by this authorK. Yong
Haematology, Royal Free and Middlesex Hospital Medical School, London, UK and
Search for more papers by this authorAbstract
Abnormal CD4/CD8 ratios and T-cell function have previously been shown in patients with B-chronic lymphocytic leukaemia (B-CLL). We have demonstrated that CD4+ T cells containing both serine esterase and perforin (PF) are increased in the blood of these patients. Using flow cytometry, we have shown that the CD4+ PF+ cells were CD57+ but lacked expression of CD28, suggesting a mature population. The same phenotype in CD8+ T cells is characteristic of mature cytotoxic T cells. However, in contrast to the CD8+ T cells, the CD4+ T cells were more frequently CD45RO positive than CD45RA positive, indicating prior antigen experience. In contrast, this population lacked expression of either CD69 or HLA-DR, arguing that they were not activated or that they are an abnormal population of T cells. Their constitutive cytokine levels showed them mainly to contain IL4 and not IFNγ, suggesting a Th2 phenotype. The role of the CD4+ PF+ T-cell population is at present uncertain. However, this potentially cytotoxic T-cell population could contribute both to enhancing survival of the B-CLL tumour cells through production of IL4, and to the immunodeficient state frequently seen in patients with this tumour, independent of drug treatment.
References
- 1 Kay NE & Perri RT. Immunobiology of malignant B cells and immunoregulatory cells in B chronic lymphocytic leukemia. Clin Lab Med 1988; 8: 163–77.
- 2 Zaknoen SL & Kay NE. Immunoregulatory cell dysfunction in chronic B cell leukemias. Blood 1990; 4: 165–74.
- 3 Bartik MM, Welker D, Kay NF. Impairments in immune cell function in B cell chronic lymphocytic leukemia. Sem Oncol 1998; 25: 27–33.
- 4 Prieto A, Garcia-Suerez J, Reyes E et al. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Exp Haematol 1993; 21: 1563–9.
- 5 Rossi E, Matutes E, Morilla R, Owusu-Ankomah K, Heffernan AM, Catovsky D. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia 1996; 10: 494–7.
- 6 Cantwell M, Hua T, Pappas J, Kipps TJ. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nature Med 1997; 3: 984–9.
- 7 Wen T, Mellstedt H, Jondal M. Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma. J Exp Med 1990; 171: 659–66.
- 8 Serrano D, Monteiro J, Allen SL et al. Clonal expansion within the CD4 (+) CD57 (+) and CD8 (+) CD57 (+) T cell subsets in chronic lymphocytic leukemia. J Immunol 1997; 158: 1482–9.
- 9 Van den Hove LE, Van Gool SW, Van den Berghe P, Boogaerts MA, Ceuppens JL. CD57+/CD28– T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis. Leukemia 1998a; 12: 1573–82.
- 10 Trapani JA, Davis J, Sutton VR, Smyth MJ. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Op Immunol 2000; 12: 323–9.
- 11 Smith MD, Worman C, Yuksel F et al. T gamma delta-cell subsets in cord and adult blood. Scand J Immunol 1990; 32: 491–5.
- 12 Rutella S, Rumi C, Lucia MB et al. Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens. Immunol Lett 1998; 60: 51–5.
- 13 Hannet I, Erkeller-Yuksel F, Lydyard P, Denys V, DeBruyere M. Development and maturational changes in human lymphocyte subpopulations. Immunol Today 1992; 13: 215–8.
- 14 Mollet L, Sadat-Sowti B, Duntze J et al. CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol 1998; 10: 311–23.
- 15 Hall H, Deutzmann R, Timpl R et al. HNK-1 carbohydrate-mediated cell adhesion to laminin-1 is different from heparin-mediated and sulfatide-mediated cell adhesion. Eur J Biochem 1997; 246: 233–42.
- 16
Schmidt JT &
Schachner M.
Role for cell adhesion and glycosyl (HNK-1 and oligomannoside) recognition in the sharpening of the regenerating retinotectal projection in goldfish.
J Neurobiol
1998; 37: 659–71.
10.1002/(SICI)1097-4695(199812)37:4<659::AID-NEU13>3.0.CO;2-3 CAS PubMed Web of Science® Google Scholar
- 17 Weekes MP, Wills MR, Mynard K et al. Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+CD28–CD8+ T cell population. Immunology 1999; 98: 443–9.
- 18 Borthwick NJ, Lowdell M, Salmon M, Akbar AN. Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor gamma chain signalling cytokines and type 1 IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol 2000; 12: 1005–13.DOI: 10.1093/intimm/12.7.1005
- 19 Romagnani P, Annunziato F, Piccinni M-P, Maggi E, Romagnani S. Cytokines and chemokines in T lymphopoiesis and T cell effector function. Immunol Today 2000; 21: 416–8.DOI: 10.1016/S0167-5699(00)01670-4
- 20 De Totero D, Reato G, Mauro F et al. IL4 production and increased CD30 expression by a unique CD8+ T cell subset in B-cell chronic lymphocytic leukemia. Br J Haematol 1999; 104: 589–99.
- 21 Brinkmann V & Kristofic C. Massive production of Th2 cytokines by human CD4+ effector T cells transiently expressing the natural killer cell marker CD57/HNK1. Immunology 1997; 91: 541–7.
- 22 Bouzahzah F, Bosseloir A, Heinen E, Simar LJAD. Human germinal center CD4+CD57+ T cells act differently on B cells than do classical T-helper cells. Dev Immunol 1995; 4: 189–97.
- 23 Hufert FT, Van Lunzen J, Janossy G et al. Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS 1997; 11: 849–57.
- 24 Conradt P, Hess J, Kaufmann SH. Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin. Microbe-Inf 1999; 1: 753–64.
- 25 Munz C, Bickham KL, Subklewe M et al. Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J Exp Med 2000; 191: 1649–60.
- 26 Ehret R, Heikelein M, Siciliano RF, Jassoy C. Human immunodeficiency virus glycoprotein-specific CD4+ cytotoxic T lymphocytes are involved in two types of cytotoxicity: antigen-specific and cell-cell fusion-related cell lysis. AIDS Res Hum Retroviruses 1997; 13: 1017–21.
- 27 Chu P, Deforce D, Rassenti LZ, Kipps T. Characterization of CD4 cytotoxic T cells specific for autologous chronic lymphocytic leukemia B cells. Blood 2000; (Suppl.): 157a.
- 28 Bohlen H, Hopff T, Manzke O et al. Lysis of malignant B cells from patients with B-chronic lymphocytic leukaemia by autologous T cells activated with CD3xCD19 bispecific antibodies in combination with bivalent CD28 antibodies. Blood 1993; 82: 1803–12.
- 29 Perambakam S, Naresh K, Nerurkar A, Nadkarni J. Intra-tumoral cytolytic cells. Pattern of distribution in B-cell non Hodgkins lymphoma. Path Oncol Res 2000; 6: 114–7.
- 30 Hahn S & Erb P. The immunomodulatory role of CD4-positive cytotoxic T-ymphocytes in health and disease. Int Rev Immunol 1999; 18: 449–64.
- 31 Xanthou G, Tapinos NI, Polihronis M et al. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjogren's syndrome. Clin Exp Immunol 1999; 118: 154–63.
- 32 Shustov A, Luzina I, Nguyen P et al. Role of perforin in controlling B cell hyperactivity and humoral autoimmunity. J Clin Invest 2000; 106: R39–R47.
- 33 Pu QQ & Bezdowa WR. Interleukin-4 prevents spontaneous in vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity. Br J Haematol 1997; 98: 413–7.
- 34 Porakishvili N, Kulikova N, Elliott S et al. Apoptosis of leukaemic cells in patients with B chronic Lymphocytic Leukaemia (B-CLL) induced by the ligation of CD5. Blood 1999; 94 (Suppl. 1): 313b.
- 35 Lewinsohn DM & Bement TTet al. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J Immunol 1998; 160: 2374–9.
- 36 Chu P, Wierda WG, Kipps TJ. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocyte. Blood 2000; 95: 3853–8.